Thermo Fisher Scientific, Inc. and Eli Lilly and Co. have expanded their clinical trial materials supply chain relationship. As part of a new five-year agreement, the Fisher Clinical Services business of Thermo Fisher will take over for Lilly’s in-house clinical trial materials manufacturing, packaging and labeling operations at Lilly’s Technology Center in Indianapolis. This transition is expected to be complete this summer. Additionally, Fisher Clinical Services will take over the distribut...